LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,000 | +50.0% | 32 | +23.1% | 0.00% | – |
| Q2 2022 | $2,000 | +100.0% | 26 | +225.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 8 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | -97.1% | 8 | -96.9% | 0.00% | -100.0% |
| Q3 2021 | $35,000 | +29.6% | 256 | +21.9% | 0.00% | +100.0% |
| Q2 2021 | $27,000 | +50.0% | 210 | +78.0% | 0.00% | 0.0% |
| Q1 2021 | $18,000 | +125.0% | 118 | +43.9% | 0.00% | -50.0% |
| Q4 2020 | $8,000 | -97.6% | 82 | -97.7% | 0.00% | -90.9% |
| Q3 2020 | $338,000 | -7.9% | 3,548 | +8.1% | 0.02% | -8.3% |
| Q2 2020 | $367,000 | -18.4% | 3,281 | -47.0% | 0.02% | -31.4% |
| Q1 2020 | $450,000 | +782.4% | 6,196 | +3231.2% | 0.04% | +775.0% |
| Q3 2018 | $51,000 | -99.8% | 186 | +66.1% | 0.00% | +100.0% |
| Q2 2018 | $23,204,000 | +580000.0% | 112 | +250.0% | 0.00% | – |
| Q4 2017 | $4,000 | 0.0% | 32 | +14.3% | 0.00% | – |
| Q3 2017 | $4,000 | -97.8% | 28 | -98.1% | 0.00% | -100.0% |
| Q2 2016 | $179,000 | – | 1,499 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |